Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT07389473. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT07389473
Prescription Psychotropic Medications for ADHD; Depression Disorders; Mood Disorders; Anxiety Disorder Generalized; Bipolarity
This study is recruiting in the United States. It is testing prescription Psychotropic Medications for ADHD; Depression Disorders; Mood Disorders; Anxiety Disorder Generalized; Bipolarity.
ADHDDrugFrom 18 Years to 65 Years
Key information made simple
This observational study is following people with Adhd, Depression Disorders, anxiety Generalized, or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
Your next step
The official record suggests a mix of remote and in-person participation through a clinic, with sites including Gaize in Philadelphia. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually having a stable enough treatment background for the study and meeting the main study requirements, while common reasons not to take part include pregnancy or breastfeeding and other factors that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Gaize
- Sponsor type
- Unknown or unclear
- Main activity
- medication or study treatment
- Intervention
- Prescription Psychotropic Medications
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
- Condition
- ADHD; Depression Disorders; Mood Disorders; Anxiety Disorder Generalized; Bipolar Disorder (BPD)
- Study status
- Recruiting
- Sponsor / lead affiliation
- Gaize
- Intervention
- Prescription Psychotropic Medications
- Location / country
- United States
- Contact
- Apurva Raje Research Coordinator / Principal Investigator, BA, Rob Kaufmann CTO, Apurva Raje Research Coordinator / Principal Investigator
- apurva.raje@gaize.ai, rob.kaufmann@gaize.ai
- Phone
- 732-397-1795
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07389473
Why this study may matter
This study may matter because it is evaluating Prescription Psychotropic Medications in a structured research setting. For people exploring bipolarity research, clear information about the goal, status, contacts, and official source can support better questions before any decision.
For you
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Mixes in-person and remote participation.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07389473
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Prescription Psychotropic Medications for ADHD; Depression Disorders; Mood Disorders; Anxiety Disorder Generalized; Bipolarity?
This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Gaize. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve medication or study treatment, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me